TheraDiag SA (ALTER):企業の財務・戦略的SWOT分析

◆英語タイトル:TheraDiag SA (ALTER) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C14771
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD300 ⇒換算¥44,400見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD600 ⇒換算¥88,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥133,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Theradiag SA (Theradiag), formerly Biomedical Diagnostics SA, is a biotechnology company that develops, manufactures, and markets vitro diagnostic products. The company offers product for the diagnostics of auto-immune diseases, allergies and infectious diseases. It develops product panels for diagnosing autoimmune diseases, allergies, and infectious diseases. Theradiag provides tests using techniques and automatic devices and solutions for high-speed diagnostics. The company also offers multi-parametric monitoring system for treatment of autoimmune diseases by anti-TNF. It provides in-vitro diagnostic products in the fields of auto-immunity, allergies, infectious diseases and, more recently, oncology and molecular biology. The company serves autoimmune disease diagnostic markets. Theradiag is headquartered in Paris, France.

TheraDiag SA Key Recent Developments

Feb 20,2019: Theradiag reports annual revenues for 2018 and its year-end cash position
Dec 11,2018: TheraDiag names Bertrand de Castelnau as Chief Executive Officer
Oct 31,2018: Appointment of Pierre Morgon as chairman of the board of directors of Theradiag
Oct 09,2018: Evolution of Theradiag’s governance
Sep 19,2018: Theradiag: 2018 interim results and business update

This comprehensive SWOT profile of TheraDiag SA provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of TheraDiag SA including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

TheraDiag SA – Key Information
TheraDiag SA – Overview
TheraDiag SA – Key Employees
TheraDiag SA – Key Employee Biographies
TheraDiag SA – Key Operational Heads
TheraDiag SA – Major Products and Services
TheraDiag SA – History
TheraDiag SA – Company Statement
TheraDiag SA – Locations And Subsidiaries
TheraDiag SA – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

TheraDiag SA – Business Description
TheraDiag SA – Corporate Strategy
TheraDiag SA – SWOT Analysis
SWOT Analysis – Overview
TheraDiag SA – Strengths
TheraDiag SA – Weaknesses
TheraDiag SA – Opportunities
TheraDiag SA – Threats
TheraDiag SA – Key Competitors

Section 3 – Company Financial Performance Charts

TheraDiag SA – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

TheraDiag SA, Key Information
TheraDiag SA, Key Ratios
TheraDiag SA, Share Data
TheraDiag SA, Major Products and Services
TheraDiag SA, History
TheraDiag SA, Key Employees
TheraDiag SA, Key Employee Biographies
TheraDiag SA, Key Operational Heads
TheraDiag SA, Other Locations
TheraDiag SA, Subsidiaries
TheraDiag SA, Key Manufacturing facilities
TheraDiag SA, Key Competitors
TheraDiag SA, SWOT Analysis
TheraDiag SA, Ratios based on current share price
TheraDiag SA, Annual Ratios
TheraDiag SA, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

TheraDiag SA, Performance Chart
TheraDiag SA, Ratio Charts

★海外企業調査レポート[TheraDiag SA (ALTER):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Calumet Specialty Products Partners, L.P.:企業のM&A・事業提携・投資動向
    Calumet Specialty Products Partners, L.P. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Calumet Specialty Products Partners, L.P. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detaile …
  • Triple Energy Ltd (TNP):企業の財務・戦略的SWOT分析
    Summary Triple Energy Ltd (Triple Energy) is an oil and gas company that explores for natural resources. The company invests in oil and gas projects in the conventional and unconventional sectors such as coal seam gas and shale oil and gas, along with power generation. It offers project such as CFT …
  • Al Mouwasat Medical Services Company (4002):企業の財務・戦略的SWOT分析
    Summary Al Mouwasat Medical Services Company (Mouwasat Medical) is a healthcare service provider that provides health and skincare services. The centre offers services in health care, skin care, and fertility treatment. It provides clinical pharmacy services such as verifying dosages appropriateness …
  • Ivy Cosmetics Corporation:企業の戦略・SWOT・財務分析
    Ivy Cosmetics Corporation - Strategy, SWOT and Corporate Finance Report Summary Ivy Cosmetics Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Aon plc:企業のM&A・事業提携・投資動向
    Aon plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Aon plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital ra …
  • Kumiai Chemical Industry Co Ltd (4996):企業の財務・戦略的SWOT分析
    Summary Kumiai Chemical Industry Co Ltd (Kumiai Chemical) operates as a chemical company that develops, manufactures and markets agricultural chemicals, fine chemicals, and curing agents. The company's agricultural chemicals include bactericides, herbicides, fungicides, acaricides, microbial pestici …
  • Applied Genetic Technologies Corp (AGTC):医療機器:M&Aディール及び事業提携情報
    Summary Applied Genetic Technologies Corp (AGTC) is a pharmaceutical company that provides development of eye disease cures. The company develops treatments for patients that have diseases caused by broken genes. It offers products such as x-linked retinoschisis, achromatopsia, x-linked retinitis pi …
  • V. F. Corporation:企業の戦略・SWOT・財務情報
    V. F. Corporation - Strategy, SWOT and Corporate Finance Report Summary V. F. Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Control4 Corporation (CTRL)-エネルギー分野:企業M&A・提携分析
    Summary Control4 Corporation (Control4) is a provider of automation systems and control solutions for homes and businesses. It focuses on smart lighting, networking solutions and safety and security solutions. The company offers personalized control solutions for lighting, video, music, energy and s …
  • Canon Inc.:企業の戦略・SWOT・財務情報
    Canon Inc. - Strategy, SWOT and Corporate Finance Report Summary Canon Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • UNIQA Biztosito Zrt.:企業の戦略・SWOT・財務情報
    UNIQA Biztosito Zrt. - Strategy, SWOT and Corporate Finance Report Summary UNIQA Biztosito Zrt. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Aero Simulation, Inc.:企業の戦略・SWOT・財務情報
    Aero Simulation, Inc. - Strategy, SWOT and Corporate Finance Report Summary Aero Simulation, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Hexion Inc.:企業の戦略・SWOT・財務情報
    Hexion Inc. - Strategy, SWOT and Corporate Finance Report Summary Hexion Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Esperion Therapeutics Inc (ESPR)-製薬・医療分野:企業M&A・提携分析
    Summary Esperion Therapeutics Inc (Esperion) is a pharmaceutical company that develops and commercializes oral therapies to treat patients with elevated low-density lipoprotein cholesterol (LDL-C). The company’s lead product candidate, Bempedoic acid, an ATP-citrate lyase inhibitor which is in Phase …
  • Lumos Pharma Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Lumos Pharma Inc (Lumos Pharma) is a developer of novel therapies for the treatment of rare and neglected diseases. The company’s pipeline product includes LUM-001, LUM-201 and LUM-301. Its lead compound LUM001, is a small and planar molecule used for the treatment of rare disease, creatine …
  • Nippon Soda Co., Ltd. (4041):企業の財務・戦略的SWOT分析
    Nippon Soda Co., Ltd. (4041) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Hokuriku Electric Power Co (9505):企業の財務・戦略的SWOT分析
    Hokuriku Electric Power Co (9505) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Insulet Corp (PODD)-医療機器分野:企業M&A・提携分析
    Summary Insulet Corp (Insulet) is a medical device company that develops, manufactures and distributes OmniPod insulin management system, an insulin infusion system for diabetic patients. OmniPod insulin management system consists of OmniPod, a disposable insulin infusion device and the Personal Dia …
  • Angel Yeast Co Ltd:企業の戦略・SWOT・財務情報
    Angel Yeast Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Angel Yeast Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Global Dominion Access SA:企業の戦略・SWOT・財務分析
    Global Dominion Access SA - Strategy, SWOT and Corporate Finance Report Summary Global Dominion Access SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆